Kicau ICO!: CURAIZON - FIRST AND ONLY THE PLATFORM OF THE WORLD WHICH CHECKS THE LESSER DRUG DRUGS

Every day, millions of people do not take their medicines as prescribed by doctors, and as a result, the cost of producing drugs increases. Worldwide, non-compliance with these requirements costs $ 700 billion. These costs help reduce the CURAIZON project.

The data created by CURAIZON is unique and very valuable for pharmaceutical companies, researchers and governments around the world.

Every time a patient uses CuraServe technology, the project database is updated with useful new information and gets more value.

The CURAIZON project every day collects full anonymous data about how and when patients use drugs.

Cura Tokens Tokens are the only way to access our database. These tokens can be used to access data that will advance medical research to reduce health care costs and save millions of lives.

The value of the CuraToken token is based on a real solution to real global problems.

What does the company do?

We aim to improve drug adherence and bring benefits that change the game for patients and healthcare providers by becoming the leading supplier of compliance and data solutions worldwide.

What's unique about the company?

Our solutions work with patients, their families, and health care providers to ensure that patients take their medication as prescribed through a series of outreach tools, supported by predictive modeling tools and behavioral analysis, to improve drug adherence levels.

What problem does the company solve?

Our CuraServe technology helps ensure that patients take their medication as prescribed by their doctor. By doing this, we help patients live longer and healthier lives. We also reduce the cost of health care that occurs when patients fail to take their medication properly.

How do you create value to support your CuraTokens?

Our CuraServe ™ technology generates a large amount of unique and real-time data that shows how people use their most valuable medicines for various groups including pharmaceutical companies, medical researchers, and biotech companies. CuraTokens ™ allows the token owner to access data to create queries. When our solution was launched to more patients in more countries. The more data we generate, the more valuable that CuraTokens ™ becomes.

Who is your target customer?

Curaizon ™ sells its compliance solutions (CuraServe ™) to national health services worldwide. Our end users are health care patients who take any form of medication. We also work with industry academia, pharmacy and biotechnology, as well as other data users through our CuraData ™ solution.

What is your geographic target market?

Curaizon targets countries with national health services. It currently includes 1.4 billion people and that number continues to grow.

What is the market potential?

The global cost of noncompliance is over € 600 billion annually and generates hundreds of thousands of lives lost prematurely. Adherence to chronic and long-term diseases is less than 50%.